Breast Cancer 2024 Review

Breast Cancer 2024 Review

BREAST CANCER REVIEW 2024 Latest treatment updates in Early Breast Cancer Peter Dubsky Highlighted data of 2024 in HER2+ / HR+ Adv. Breast Cancer Nadia Harbeck Practice-changing studies of 2024 in advanced TNBC Khalil Zaman  } 1 h 32 min Get Your CME...
Antibody Drug Conjugates

Antibody Drug Conjugates

Antibody Drug Conjugates WELCOME & INTRODUCTION BY HOST Alessandra Curioni EMERGING TRENDS & CLINICAL IMPACT OF ADCs IN GENITOURINARY CANCERS Giuseppe Banna CURRENT AND FUTURE STANDARDS OF ADCs IN BREAST CANCER CARE Paolo Tarantino NEW DEVELOPMENTS IN LUNG CANCER CARE...
Gynecological Cancers

Gynecological Cancers

Gynecological Cancers Welcome & introduction by host Apostolos Sarivalasis Latest treatment updates for endometrial cancer Ilaria Colombo Navigating treatment strategies for ovarian cancer Christina Fotopoulou New developments in cervical cancer management Apostolos...
Breast Cancer (ASCO 2024)

Breast Cancer (ASCO 2024)

Breast Cancer (ASCO 2024) Welcome & introduction by host Jens Huober Latest treatment updates in early breast cancer Konstantin Dedes How does the latest ASCO data integrate into the treatment of TNBC and HER2+ advanced breast cancer? Isabell Witzel Where do we stand...
HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...